Literature DB >> 15970437

Tissue- and bone cell-specific expression of bone sialoprotein is directed by a 9.0 kb promoter in transgenic mice.

J Paz1, K Wade, T Kiyoshima, J Sodek, J Tang, Q Tu, M Yamauchi, J Chen.   

Abstract

Bone sialoprotein (BSP) is a phosphorylated glycoprotein that is expressed almost exclusively in mineralizing connective tissues. In bone, expression of BSP correlates with the differentiation of osteoblasts and the onset of mineralization. To determine how the tissue- and differentiation-specific transcription of BSP is regulated, various lengths of promoter sequence were ligated to a luciferase reporter and stably transfected into a rat stromal bone marrow cell line, RBMC-D8 and undifferentiated C3H10T1/2 cells. Luciferase transcription of reporter constructs including 5.4 kb (mBSP5.4Luc) and 9.0 kb (mBSP9.0Luc) of the BSP promoter was strongly up-regulated in parallel with endogenous BSP mRNA in differentiating SBMCs, but not in C3H10T1/2 cells. In contrast, 0.1 kb and 1.4 kb BSP promoter constructs did not show selective expression. To determine tissue-specific expression in vivo, transgenic mice expressing reporter constructs for the 9.0 kb promoter and a 4.8 kb promoter lacking two upstream Cbfa1/Runx2 elements (mBSP9.0Luc and mBSP4.8Luc, respectively) were generated. Analysis of various tissues collected from 1-, 4-, 7-, 14-, and 42-day-old mice revealed extremely high levels of luciferase activity in calvaria, mandible, and tibia of the mBSP9.0Luc mice. In contrast, soft tissues showed negligible luciferase expression. Mice harboring the 4.8 kb transgene also showed selective luciferase expression but displayed a significantly lower activity in mineralized tissues. Northern hybridization of endogenous BSP mRNA and immunostaining of BSP in mBSP9.0Luc mice showed a temporo-spatial expression pattern consistent with the luciferase activity. These results indicate that regulatory elements within the 9.0 kb region of the promoter are required for strong, tissue- and differentiation-specific expression of BSP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15970437     DOI: 10.1016/j.matbio.2005.05.009

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  10 in total

1.  Systemically transplanted bone marrow stromal cells contributing to bone tissue regeneration.

Authors:  S Li; Q Tu; J Zhang; G Stein; J Lian; P S Yang; J Chen
Journal:  J Cell Physiol       Date:  2008-04       Impact factor: 6.384

2.  p38 regulates expression of osteoblast-specific genes by phosphorylation of osterix.

Authors:  María José Ortuño; Silvia Ruiz-Gaspà; Edgardo Rodríguez-Carballo; Antonio R G Susperregui; Ramon Bartrons; José Luis Rosa; Francesc Ventura
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

3.  Roles of SATB2 in osteogenic differentiation and bone regeneration.

Authors:  Jin Zhang; Qisheng Tu; Rudolf Grosschedl; Min Seok Kim; Terrence Griffin; Hicham Drissi; Pishan Yang; Jake Chen
Journal:  Tissue Eng Part A       Date:  2011-04-21       Impact factor: 3.845

4.  Haploinsufficiency of Runx2 results in bone formation decrease and different BSP expression pattern changes in two transgenic mouse models.

Authors:  Qisheng Tu; Jin Zhang; Jeff Paz; Katherine Wade; Pishan Yang; Jake Chen
Journal:  J Cell Physiol       Date:  2008-10       Impact factor: 6.384

5.  Phenotypic analysis of Dlx5 overexpression in post-natal bone.

Authors:  J Zhang; J Zhu; P Valverde; L Li; S Pageau; Q Tu; R Nishimura; T Yoneda; P Yang; W Zheng; W Ma; J Chen
Journal:  J Dent Res       Date:  2008-01       Impact factor: 6.116

6.  Overexpression of bone sialoprotein leads to an uncoupling of bone formation and bone resorption in mice.

Authors:  Paloma Valverde; Jin Zhang; Amanda Fix; Ji Zhu; Wenli Ma; Qisheng Tu; Jake Chen
Journal:  J Bone Miner Res       Date:  2008-11       Impact factor: 6.741

Review 7.  Applications of transgenics in studies of bone sialoprotein.

Authors:  Jin Zhang; Qisheng Tu; Jake Chen
Journal:  J Cell Physiol       Date:  2009-07       Impact factor: 6.384

8.  Osterix enhances BMSC-associated osseointegration of implants.

Authors:  B Xu; J Zhang; E Brewer; Q Tu; L Yu; J Tang; P Krebsbach; M Wieland; J Chen
Journal:  J Dent Res       Date:  2009-11       Impact factor: 6.116

9.  Targeted overexpression of BSP in osteoclasts promotes bone metastasis of breast cancer cells.

Authors:  Qisheng Tu; Jin Zhang; Amanda Fix; Erika Brewer; Yi-Ping Li; Zhi-Yuan Zhang; Jake Chen
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

10.  Genomic occupancy of Runx2 with global expression profiling identifies a novel dimension to control of osteoblastogenesis.

Authors:  Hai Wu; Troy W Whitfield; Jonathan A R Gordon; Jason R Dobson; Phillip W L Tai; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Genome Biol       Date:  2014-03-21       Impact factor: 13.583

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.